Disclosures for "Synergistic and Distinct Central Effects of Dapagliflozin and Exenatide on Brain Networks Intrinsic Connectivity in Obesity and Type 2 Diabetes: A Randomized Controlled Trial"
-
Mr. Dos Santos Silva has nothing to disclose.
-
Author has nothing to disclose
-
Dr. IJzerman has nothing to disclose.
-
Mr. van Duinkerken has nothing to disclose.